Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CytomX Therapeutics

Request full access

Early-stage biotechnology company developing probodies, proteolytically-activated antibodies

South San Francisco, United StatesFounded 2008Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2015

CytomX Therapeutics in the South San Francisco ecosystem

Live from Dealroom

The CytomX Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$156M

80 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See CytomX Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.